+1 862-686-2696
Featured Products
Primary Cells
Immortalized Cell Lines
Stem Cells
Tumor Cell Lines
Transfected Stable Cell Lines
Exosomes
MicroRNA Agomir/Antagomir
Cell Culture Media, Kits & Reagents
Explore Products
Cell
Cell
MicroRNA
MicroRNA
Test and Analysis
Test and Analysis
Primary Cells

Human Chronic Lymphoid Leukemia Bone Marrow Plasma (Newly Diagnosed/Untreated)

  • For research use only

Cat No.

ABC-TC3344
Product Type

Blood Products
Cell Type

Plasma
Species

Human
Growth Conditions

37 ℃, 5% CO2
Source Organ

Bone Marrow
Disease

Chronic Lymphoid Leukemia
Storage

Liquid Nitrogen

Human Chronic Lymphoid Leukemia Bone Marrow Plasma supports biomarker discovery, immune profiling, and monitoring in newly diagnosed or untreated CLL.

Product Image
  • Human Chronic Lymphoid Leukemia Bone Marrow Plasma (Newly Diagnosed/Untreated)
Get a Quote
Home | Primary Cells | Human Primary Cells | Blood System Primary Cells | Human Chronic Lymphoid Leukemia Bone Marrow Plasma (Newly Diagnosed/Untreated)

Description

Human Chronic Lymphoid Leukemia Bone Marrow Plasma (Newly Diagnosed/Untreated) is isolated from the bone marrow aspirates of patients with clinically confirmed, untreated chronic lymphocytic leukemia (CLL) at the time of diagnosis. The plasma component contains a complex mixture of soluble factors including cytokines, chemokines, and circulating tumor-derived extracellular vesicles, which reflect the disease microenvironment. This product is cell-free and collected under stringent conditions to preserve native protein and vesicle profiles. It is cryopreserved immediately after isolation to maintain biomolecular integrity. This product should not be subjected to repeated freeze-thaw cycles to avoid degradation of bioactive components. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.

Product Code

Human Chronic Lymphoid Leukemia Bone Marrow Plasma (Newly Diagnosed/Untreated), Human CLL Bone Marrow Plasma, Bone Marrow Plasma, Plasma
Species

Human
Cat.No

ABC-TC3344
Product Category

Primary Cells
Size/Quantity

1 vial
Cell Type

Plasma
Shipping Info

Dry Ice
Growth Conditions

37 ℃, 5% CO2
Source Organ

Bone Marrow
Disease

Chronic Lymphoid Leukemia
Biosafety Level

1
Storage

Liquid Nitrogen
Product Type

Blood Products
Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Application

  • CLL Bone Marrow Plasma (Newly Diagnosed/Untreated) serves as a relevant model for studying tumor-host interactions, immune evasion, and biomarker discovery in early-stage CLL, providing a valuable system for new CLL diagnosis analysis. It is particularly useful in proteomic or transcriptomic profiling studies to identify signatures associated with treatment-naïve disease. Additionally, it can be applied in ex vivo assays assessing drug response, or in the validation of plasma-based diagnostic or prognostic biomarkers.It also serves as a functional matrix in co-culture or conditioned media experiments to replicate CLL-associated soluble signaling.

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

  • Online Inquiry
  • Product Reviews

Inquiring Human Chronic Lymphoid Leukemia Bone Marrow Plasma (Newly Diagnosed/Untreated)

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

Let's Advance Life Science Research Together

Contact Us
AcceGen Scroll Top Button